Based in Hong Kong with more than 200 employees, Insilico Medicine develops an AI platform for drug development to treat cancer and age-related diseases.Alex Zhavoronkov is its founder and CEO. (Prosperity7 is the diversified growth fund of Aramco Ventures, a subsidiary of Aramco, the Saudi energy and chemicals company, with $1 billion venture capital fund and a global investment strategy in all sectors)
Prosperity7 Ventures is listed in the Middle East Investors Directory with the code BJ96.
Previous Post: Saudi investors of Sanabil and consortium invested $52 million in US jobs app
Next Post: Qatar investors of QIA and consortium acquired stake in German software firm for $400 million